Gudrun E. Lindmark
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Prognostic Role of EMR1 in Lymph Nodes and Primary Tumors of Colon Cancer Patients.
Journal: Advanced biology
Published: October 21, 2025
Combined serine protease PRSS22 and CEA mRNA analysis identifies the majority of colon cancer patients that recur within 12 years.
Journal: Frontiers in oncology
Published: May 27, 2025
High IL-10 mRNA levels in regional lymph nodes of colon cancer patients indicate poor prognosis.
Journal: Frontiers in immunology
Published: March 07, 2025
LGR6 is a prognostic biomarker for less differentiated tumors in lymph nodes of colon cancer patients.
Journal: Frontiers in oncology
Published: February 28, 2024
Detection of lymph node metastasis in colon cancer by ectopically expressed fibroblast markers FOXQ1 and THBS2.
Journal: Frontiers in oncology
Published: September 19, 2023
qRT-PCR analysis of CEACAM5, KLK6, SLC35D3, MUC2 and POSTN in colon cancer lymph nodes-An improved method for assessment of tumor stage and prognosis.
Journal: International journal of cancer
Published: May 31, 2023
Prognostic Significance of GPR55 mRNA Expression in Colon Cancer.
Journal: International journal of molecular sciences
Published: March 28, 2022
Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients.
Journal: International journal of molecular sciences
Published: December 13, 2021
The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 06, 2021
CEACAM5, KLK6, SLC35D3, POSTN, and MUC2 mRNA Analysis Improves Detection and Allows Characterization of Tumor Cells in Lymph Nodes of Patients Who Have Colon Cancer.
Journal: Diseases of the colon and rectum
Published: June 30, 2021
Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 10, 2020
The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.
Journal: International journal of molecular sciences
Published: October 15, 2019
Last Updated: 09/26/2026